AI Overview

ICBC a l'intention d'accorder des prolongations de contrat d'un an à plusieurs conseillers cliniques pour la prestation continue des services du Groupe consultatif clinique pendant que le programme subit une transformation importante.

Information de base

Numéro de Référence

00004907383

Organisation émettrice

Insurance Corporation of BC

Type d’appel d’offres

AI - Avis d’intention (Informel)

Numéro d’appel d’offres

225175

Titre

Clinical Advisory Group

Code d’identité d’origine

SCRIBE

Détails

Emplacement

Colombie Britannique

Type d’achat

Non-mentionné

Dates

Publication

2026-02-17 08h00:00 HNE

Date de fermeture

2026-03-23 15h00:00 HAE

Information du contact

Strategic Sourcing

sourcing@icbc.com

Description

The Insurance Corporation of British Columbia (ICBC) hereby gives notice that it intends to direct award one-year contract extensions to the following suppliers for continued provision of Clinical Advisory Group (CAG) services. These extensions are required to allow sufficient time for the redesign of the CAG program and ensure uninterrupted access to qualified medical and clinical advisors across multiple disciplines to support ICBC’s Enhanced Care operations.

• Dr. O. R. Abu Inc.
• Dr. Rishi Bhalla, Inc.
• Dr. Salim Ebrahim Inc.
• Dr. Oliver Leslie
• Dr. Samuel Obamiyi
• Dr. Nicholas Rose Inc.
• Dr. S. Shergill Professional Corp
• Dr. Bryn Sharkey
• Dr. K. Briar Sexton Inc.
• Gaelan Connell
• Giovanna Boniface
• Lauren Yuen (DBA LY Occupational Therapy Services)
• Stella Melina Kurtakis

The term of each contract extension is, from April 1, 2026, to March 31, 2027. The estimated aggregate value of these extensions is approximately $1.2 million, plus applicable taxes.

ICBC further advises that it intends to conduct a competitive procurement process for the provision of CAG services, utilizing a refreshed service model, by the end of the one-year extension period. The posting of this procurement opportunity is estimated to occur by Q4, 2026.

Rationale:
The clinical advisors listed above form ICBC’s Clinical Advisory Group and collectively provide advisory services that support Enhanced Care Operations. These advisors are required to deliver objective, evidence‑informed clinical opinions and possess an in‑depth understanding of ICBC’s operational context, program protocols, and workflows necessary for the effective provision of these services.

The Clinical Advisory Program is undergoing significant transformation, including the redesign of core advisory processes and the development of a future‑state service model that will inform ICBC’s long‑term needs for these services. During this redesign period, uninterrupted access to consistent clinical expertise is essential to maintaining effective Enhanced Care Operations. Therefore, to ensure service continuity and mitigate the risk of service gaps while the new advisory framework is being finalized, ICBC must extend the active agreements for the period outlined in this notice.

Afficher davantage

Dérogation All amendments to the associated notice, including amended documents, plans and specifications (where applicable), are issued on bcbid.gov.bc.ca. MERX asks that you refer to bcbid.gov.bc.ca notice for these amendments. MERX stipulates that potential bidders may also be required to register with the buying authority as a bidder/plan taker. The contact information can be found within the notice abstract.